ABSTRACT
A 9-day-old girl presented during the 2020 SARS-CoV-2 pandemic in wide-complex tachycardia with acute, symptomatic COVID-19 infection. Because the potential cardiac complications of COVID-19 were unknown at the time of her presentation, we chose to avoid the potential risks of haemodynamic collapse associated with afterload reduction from adenosine. Instead, a transoesophageal pacing catheter was placed. Supraventricular tachycardia (SVT) with an aberrated QRS morphology was diagnosed and the catheter was used to pace-terminate tachycardia. This presentation illustrates that the haemodynamic consequences of a concurrent infection with largely unknown neonatal sequelae present a potentially high-risk situation for pharmacologic conversion. Oesophageal cannulation can be used to diagnose and terminate infantile SVT.
Subject(s)
COVID-19 , Fever , Tachycardia, Supraventricular , COVID-19/complications , COVID-19/diagnosis , Female , Fever/virology , Humans , Infant, Newborn , Tachycardia, Supraventricular/virologyABSTRACT
Respiratory syncytial virus infection is the most common cause of hospital admissions in children under 1 year of age. Various cardiac dysrrhythmias have been reported to be associated with respiratory syncytial virus infection. We report a case where both tachyarrhythmia and bradyarrhythmia occurred within the same illness. Paediatricians need to be aware of this association.
